Skip to main content

Daily Stock Pick: Bristol Myers Squibb

Unlike some of its more diversified peers, Bristol Myers Squibb has exited several non-pharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power. A key focus for the company is immuno-oncology.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.